HuGE Literature Finder
Records
1
-
30
| [Clinical features and survival analysis in non-M(3) acute myeloid leukemia patients with ASXL1 gene mutation]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (10): 833-840. Jia W B, Liu J T, Yang X Y, Wu H Y, Wei Y H, Can C, Wang R Q, He N, Gu C Y, Ma D X, Ji C |
| [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (12): 1021-1027. Su L, Tan Y H, Lin H, Han W, Yang Y P, Liu X L, Sun J N, Liu Q J, Gao S |
| Association of ABCB1, ABCG2 drug transporter polymorphisms and smoking with disease risk and cytogenetic response to imatinib in chronic myeloid leukemia patients. Leukemia research 2023 1 126 107021. Mohammadi Fatemeh, Rostami Golale, Hamid Mohammad, Shafiei Mohammad, Azizi Masoumeh, Bahmani Has |
| Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group. Journal of experimental & clinical cancer research : CR 2023 1 42 (1): 21. Junk Stefanie V, Schaeffeler Elke, Zimmermann Martin, Möricke Anja, Beier Rita, Schütte Peter, Fedders Birthe, Alten Julia, Hinze Laura, Klein Norman, Kulozik Andreas, Muckenthaler Martina U, Koehler Rolf, Borkhardt Arndt, Vijayakrishnan Jayaram, Ellinghaus David, Forster Michael, Franke Andre, Wintering Astrid, Kratz Christian P, Schrappe Martin, Schwab Matthias, Houlston Richard S, Cario Gunnar, Stanulla Mart |
| Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 2023 1 37 (2): 504. Mansouri Larry, Thorvaldsdottir Birna, Sutton Lesley-Ann, Karakatsoulis Georgios, Meggendorfer Manja, Parker Helen, Nadeu Ferran, Brieghel Christian, Laidou Stamatia, Moia Riccardo, Rossi Davide, Catherwood Mark, Kotaskova Jana, Delgado Julio, Rodríguez-Vicente Ana E, Benito Rocío, Rigolin Gian Matteo, Bonfiglio Silvia, Scarfo Lydia, Mattsson Mattias, Davis Zadie, Gogia Ajay, Rani Lata, Baliakas Panagiotis, Foroughi-Asl Hassan, Jylhä Cecilia, Skaftason Aron, Rapado Inmaculada, Miras Fatima, Martinez-Lopez Joaquín, de la Serna Javier, Rivas Jesús María Hernández, Thornton Patrick, Larráyoz María José, Calasanz María José, Fésüs Viktória, Mátrai Zoltán, Bödör Csaba, Smedby Karin E, Espinet Blanca, Puiggros Anna, Gupta Ritu, Bullinger Lars, Bosch Francesc, Tazón-Vega Bárbara, Baran-Marszak Fanny, Oscier David, Nguyen-Khac Florence, Zenz Thorsten, Terol Maria Jose, Cuneo Antonio, Hernández-Sánchez María, Pospisilova Sarka, Mills Ken, Gaidano Gianluca, Niemann Carsten U, Campo Elias, Strefford Jonathan C, Ghia Paolo, Stamatopoulos Kostas, Rosenquist Richa |
| Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity. Frontiers in oncology 2023 1 12 1079772. Sofou Electra, Zaragoza-Infante Laura, Pechlivanis Nikolaos, Karakatsoulis Georgios, Notopoulou Sofia, Stavroyianni Niki, Psomopoulos Fotis, Georgiou Elisavet, de Septenville Anne Langlois, Davi Frederic, Agathangelidis Andreas, Chatzidimitriou Anastasia, Stamatopoulos Kost |
| FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis. Frontiers in oncology 2023 3 13 1086846. Li Shuping, Li Na, Chen Yun, Zheng Zhihua, Guo Y |
| Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China. Cancer medicine 2023 2 . Li Junnan, Pei Li, Liang Simin, Xu Shuangnian, Wang Yi, Wang Xiao, Liao Yi, Zhan Qian, Cheng Wei, Yang Zesong, Tang Xiaoqiong, Zhang Hongbin, Xiao Qing, Chen Jianbin, Liu Lin, Wang |
| High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk. Clinical and experimental medicine 2023 1 . Xu Nan, Chen Wen-Min, Li Ling-Di, Long Ling-Yu, Wang Xu, Jiang Qian, Jiang Hao, Huang Xiao-Jun, Qin Ya-Zh |
| Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia. Blood advances 2023 1 . Heidenreich Falk, Falk Bose, Baldauf Henning, Massalski Carolin, Schäfer Gesine, Rücker-Braun Elke, Altmann Heidi, Sauter Jürgen, Solloch Ute, Lange Vinzenz, Stölzel Friedrich, Röllig Christoph, Middeke Jan Moritz, von Bonin Malte, Thiede Christian, Schäfer-Eckart Kerstin, Müller-Tidow Carsten, Krause Stefan W, Kraus Sabrina, Kaufmann Martin, Hänel Mathias, Serve Hubert, Neubauer Andreas, Bornhäuser Martin, Schmidt Alexander H, Schetelig Johann |
| One-Carbon (Folate) Metabolism Pathway at Birth and Risk of Childhood Acute Lymphoblastic Leukemia: A Biomarker Study in Newborns. Cancers 2023 2 15 (4): . Metayer Catherine, Imani Partow, Dudoit Sandrine, Morimoto Libby, Ma Xiaomei, Wiemels Joseph L, Petrick Lauren |
| Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 2023 1 13 (1): 4. Tsai Xavier Cheng-Hong, Sun Kuo-Jui, Lo Min-Yen, Tien Feng-Ming, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Chuang Yi-Kuang, Ko Bor-Sheng, Tang Jih-Luh, Sun Hsun-I, Liu Ming-Chih, Liu Chia-Wen, Lin Chien-Chin, Yao Ming, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study. International journal of hematology 2023 2 . Miyashita Naoki, Onozawa Masahiro, Yoshida Shota, Kimura Hiroyuki, Takahashi Shogo, Yokoyama Shota, Matsukawa Toshihiro, Hirabayashi Shinsuke, Fujisawa Shinichi, Mori Akio, Ota Shuichi, Kakinoki Yasutaka, Tsutsumi Yutaka, Yamamoto Satoshi, Miyagishima Takuto, Nagashima Takahiro, Ibata Makoto, Wakasa Kentaro, Haseyama Yoshihito, Fujimoto Katsuya, Ishihara Toshimichi, Sakai Hajime, Kondo Takeshi, Teshima Takano |
| SAMHD1 Single Nucleotide Polymorphisms Impact Outcome in Children with Newly Diagnosed Acute Myeloid Leukemia. Blood advances 2023 1 . Marrero Richard James, Cao Xueyuan, Wu Huiyun, Elsayed Abdelrahman H, Klco Jeffery M, Ribeiro Raul C, Rubnitz Jeffrey E, Ma Xiaotu, Meshinchi Soheil, Aplenc Richard, Kolb E Anders, Ries Rhonda E, Alonzo Todd, Pounds Stanley B, Lamba Jatinder Ka |
| Significance of CEBPE Gene Promoter Polymorphism (Rs2239630 G > A ) Assessment in Childhood B-cell Acute Lymphoblastic Leukemia. Journal of pediatric hematology/oncology 2023 3 . Aref Salah, El-Ghonemy Mohamed, Shimaa Hendawy, Darwish Ahmad, Abdelmabood Suzy, Khaled Na |
| The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers. Frontiers in immunology 2023 2 13 1006639. Andrzejczak Anna, Partyka Anna, Wi?niewski Andrzej, Por?bska Irena, Pawe?czyk Konrad, Ptaszkowski Kuba, Ku?nierczyk Piotr, Jasek Monika, Karabon Lid |
| The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia. Cancer medicine 2023 3 . Chen Xian, Tian Chuchu, Hao Zhuanghui, Pan Lingang, Hong Minglin, Wei Wei, Muyey Daniel Muteb, Wang Hongwei, Chen Xiuh |
| The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation. Cancers 2023 1 15 (1): . Wang Yi, Quesada Andres E, Zuo Zhuang, Medeiros L Jeffrey, Yin C Cameron, Li Shaoying, Xu Jie, Borthakur Gautam, Li Yisheng, Yang Chao, Abaza Yasmin, Gao Juehua, Lu Xinyan, You M James, Zhang Yizhuo, Lin P |
| TP53 mutations are associated with increased infections and reduced hematopoietic cell transplantation rates in myelodysplastic syndrome and acute myeloid leukemia. Transplantation and cellular therapy 2023 3 . Marvin-Peek Jennifer, Mason Emily F, Kishtagari Ashwin, Jayani Reena V, Dholaria Bhagirathbhai, Kim Tae Kon, Engelhardt Brian G, Chen Heidi, Strickland Stephen, Savani Bipin, Ferrell Brent, Kassim Adetola, Savona Michael, Mohan Sanjay, Byrne Micha |
| Whole-exome sequencing identified recurrent and novel variants in benzene-induced leukemia. BMC medical genomics 2023 1 16 (1): 13. Lin Dafeng, Wang Dianpeng, Li Peimao, Deng Lihua, Zhang Zhimin, Zhang Yanfang, Zhang Ming, Zhang Naixi |
| Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 2022 12 98 (3): E53-E56. Senapati Jayastu, Abuasab Tareq, Haddad Fadi G, Ravandi Farhad, Kadia Tapan, DiNardo Courtney, Daver Naval, Pemmaraju Naveen, Alvarado Yesid, Brandt Mark A, Kantarjian Hagop, Borthakur Gaut |
| Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 2022 12 37 (2): 339-347. Mansouri Larry, Thorvaldsdottir Birna, Sutton Lesley-Ann, Karakatsoulis Georgios, Meggendorfer Manja, Parker Helen, Nadeu Ferran, Brieghel Christian, Laidou Stamatia, Moia Riccardo, Rossi Davide, Catherwood Mark, Kotaskova Jana, Delgado Julio, Rodríguez-Vicente Ana E, Benito Rocío, Rigolin Gian Matteo, Bonfiglio Silvia, Scarfo Lydia, Mattsson Mattias, Davis Zadie, Gogia Ajay, Rani Lata, Baliakas Panagiotis, Foroughi-Asl Hassan, Jylhä Cecilia, Skaftason Aron, Rapado Inmaculada, Miras Fatima, Martinez-Lopez Joaquín, de la Serna Javier, Rivas Jesús María Hernández, Thornton Patrick, Larráyoz María José, Calasanz María José, Fésüs Viktória, Mátrai Zoltán, Bödör Csaba, Smedby Karin E, Espinet Blanca, Puiggros Anna, Gupta Ritu, Bullinger Lars, Bosch Francesc, Tazón-Vega Bárbara, Baran-Marszak Fanny, Oscier David, Nguyen-Khac Florence, Zenz Thorsten, Terol Maria Jose, Cuneo Antonio, Hernández-Sánchez María, Pospisilova Sarka, Mills Ken, Gaidano Gianluca, Niemann Carsten U, Campo Elias, Strefford Jonathan C, Ghia Paolo, Stamatopoulos Kostas, Rosenquist Richa |
| Essential Thrombocythemia: One-Center Data in a Changing Disease. Medicina (Kaunas, Lithuania) 2022 12 58 (12): . Pirciulescu Nicoleta, Gaman Mihnea-Alexandru, Mihailescu Marina, Constantin Cristina, Dragomir Mihaela, Dobrea Camelia, Costache Simona, Ursuleac Iulia, Coriu Daniel, Crisan Ana Manue |
| Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 2022 12 14 (23): . Ayala Rosa, Carreño-Tarragona Gonzalo, Barragán Eva, Boluda Blanca, Larráyoz María J, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao Cristina, Sánchez-García Joaquín, Bernal Teresa, Martinez-Cuadron David, Gil Cristina, Serrano Josefina, Rodriguez-Medina Carlos, Bergua Juan, Pérez-Simón José A, Calbacho María, Alonso-Domínguez Juan M, Labrador Jorge, Tormo Mar, Amigo Maria Luz, Herrera-Puente Pilar, Rapado Inmaculada, Sargas Claudia, Vazquez Iria, Calasanz María J, Gomez-Casares Teresa, García-Sanz Ramón, Sanz Miguel A, Martínez-López Joaquín, Montesinos P |
| Mucin (MUC) Family Influence on Acute Lymphoblastic Leukemia in Cancer and Non-Cancer Native American Populations from the Brazilian Amazon. Journal of personalized medicine 2022 12 12 (12): . Alcântara Angélica Leite de, Pastana Lucas Favacho, Gellen Laura Patrícia Albarello, Vieira Giovana Miranda, Dobbin Elizabeth Ayres Fragoso, Silva Thays Amâncio, Pereira Esdras Edgar Batista, Rodrigues Juliana Carla Gomes, Guerreiro João Farias, Fernandes Marianne Rodrigues, Assumpção Paulo Pimentel de, Cohen-Paes Amanda de Nazaré, Santos Sidney Emanuel Batista Dos, Santos Ney Pereira Carneiro D |
| Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis. Asia-Pacific journal of clinical oncology 2022 12 . Zhang Ao, Wang Shuxing, Ren Quanlei, Wang Yizhu, Jiang Zhipi |
| Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival. Cancer medicine 2022 11 . Stabellini Nickolas, Tomlinson Benjamin, Cullen Jennifer, Shanahan John, Waite Kristin, Montero Alberto J, Barnholtz-Sloan Jill S, Hamerschlak Nels |
| Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia. Wiener medizinische Wochenschrift (1946) 2022 11 173 (1-2): 27-33. Lackner David, Geissler Kla |
| Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia. Wiener medizinische Wochenschrift (1946) 2022 11 173 (1-2): 21-26. Zack Marie-Therese, Geissler Kla |
| The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients. International journal of cancer 2022 12 152 (7): 1388-1398. Wagener Rabea, Walter Carolin, Auer Franziska, Alzoubi Deya, Hauer Julia, Fischer Ute, Varghese Julian, Dugas Martin, Borkhardt Arndt, Brozou Triantafyll |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: